Make a note
$ADC Therapeutics (ADCT.US)$ ADC Therapeutics SA: Lotis-7 Trial Enrollment on Track With Efficacy and Safety Data on Eligible Patients Expected by Year-End 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
